Site icon OncologyTube

Keyan Salari, MD 5-Alpha Reductase Inhibitors and Risk of Fatal Bladder Cancer @KeyanSalari @MGHUrology

Keyan Salari, MD @KeyanSalari of Massachusetts General Hospital @MGHUrology discusses 5-alpha reductase inhibitors and risk of overall and fatal bladder cancer.

Exit mobile version